Sayer RA - Search Results

1

Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.

Havrilesky LJ, Alvarez AA, Sayer RA, Lancaster JM, Soper JT, Berchuck A, Clarke-Pearson DL, Rodriguez GC, Carney ME. Havrilesky LJ, et al. Among authors: sayer ra. Gynecol Oncol. 2003 Jan;88(1):51-7. doi: 10.1006/gyno.2002.6859. Gynecol Oncol. 2003. PMID: 12504627 Clinical Trial.

2

The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.

Alvarez Secord A, Sayer R, Snyder SA, Broadwater G, Rodriguez GC, Berchuck A, Blackwell K. Alvarez Secord A, et al. Gynecol Oncol. 2004 Jul;94(1):74-9. doi: 10.1016/j.ygyno.2004.03.043. Gynecol Oncol. 2004. PMID: 15262122

3

High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.

Lancaster JM, Sayer R, Blanchette C, Calingaert B, Whitaker R, Schildkraut J, Marks J, Berchuck A. Lancaster JM, et al. Clin Cancer Res. 2003 Feb;9(2):762-6. Clin Cancer Res. 2003. PMID: 12576447

4

Genomic signatures to guide the use of chemotherapeutics.

Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR. Potti A, et al. Nat Med. 2006 Nov;12(11):1294-300. doi: 10.1038/nm1491. Epub 2006 Oct 22. Nat Med. 2006. Retraction in: Nat Med. 2011 Jan;17(1):135. doi: 10.1038/nm0111-135 PMID: 17057710 Retracted.

5

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, Gray J, Marks J, Ginsburg GS, Potti A, West M, Nevins JR, Lancaster JM. Dressman HK, et al. J Clin Oncol. 2007 Feb 10;25(5):517-25. doi: 10.1200/JCO.2006.06.3743. J Clin Oncol. 2007. Retraction in: J Clin Oncol. 2012 Feb 20;30(6):678. doi: 10.1200/jco.2012.42.0331 PMID: 17290060 Retracted.

6

High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.

Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A. Sayer RA, et al. Gynecol Oncol. 2005 Feb;96(2):355-61. doi: 10.1016/j.ygyno.2004.10.012. Gynecol Oncol. 2005. PMID: 15661221

7

Prognostic gene expression signature for high-grade serous ovarian cancer.

Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, Chen S, Elatre W, Gilks B, Nazeran T, Volchek M, Bentley RC, Wang C, Chiu DS, Kommoss S, Leung SCY, Senz J, Lum A, Chow V, Sudderuddin H, Mackenzie R, George J; AOCS Group; Fereday S, Hendley J, Traficante N, Steed H, Koziak JM, Köbel M, McNeish IA, Goranova T, Ennis D, Macintyre G, Silva De Silva D, Ramón Y Cajal T, García-Donas J, Hernando Polo S, Rodriguez GC, Cushing-Haugen KL, Harris HR, Greene CS, Zelaya RA, Behrens S, Fortner RT, Sinn P, Herpel E, Lester J, Lubiński J, Oszurek O, Tołoczko A, Cybulski C, Menkiszak J, Pearce CL, Pike MC, Tseng C, Alsop J, Rhenius V, Song H, Jimenez-Linan M, Piskorz AM, Gentry-Maharaj A, Karpinskyj C, Widschwendter M, Singh N, Kennedy CJ, Sharma R, Harnett PR, Gao B, Johnatty SE, Sayer R, Boros J, Winham SJ, Keeney GL, Kaufmann SH, Larson MC, Luk H, Hernandez BY, Thompson PJ, Wilkens LR, Carney ME, Trabert B, Lissowska J, Brinton L, Sherman ME, Bodelon C, Hinsley S, Lewsley LA, Glasspool R, Banerjee SN, Stronach EA, Haluska P, Ray-Coquard I, Mahner S, Winterhoff B, Slamon D, Levine DA, Kelemen LE, Benitez J, Chang-Claude J, Gronwald J, Wu AH, Menon U, Goo… See abstract for full author list ➔ Millstein J, et al. Among authors: sayer r. Ann Oncol. 2020 Sep;31(9):1240-1250. doi: 10.1016/j.annonc.2020.05.019. Epub 2020 May 28. Ann Oncol. 2020. PMID: 32473302 Free PMC article.

8

Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.

Tebes SJ, Sayer RA, Palmer JM, Tebes CC, Martino MA, Hoffman MS. Tebes SJ, et al. Among authors: sayer ra. Gynecol Oncol. 2007 Sep;106(3):482-7. doi: 10.1016/j.ygyno.2007.04.006. Epub 2007 Jun 27. Gynecol Oncol. 2007. PMID: 17590420

9

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.

Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, Cragun JM, Henriott AH, Gray J, Sutphen R, Elahi A, Whitaker RS, West M, Marks JR, Nevins JR, Berchuck A. Lancaster JM, et al. Among authors: sayer ra. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1733-45. doi: 10.1111/j.1525-1438.2006.00660.x. Int J Gynecol Cancer. 2006. PMID: 17009964

10

High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels.

Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. Lancaster JM, et al. Among authors: sayer ra. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1529-35. doi: 10.1111/j.1525-1438.2006.00623.x. Int J Gynecol Cancer. 2006. PMID: 16884361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters